FDA will drop two-study requirement for new drug approvals, aiming to speed access

Source: The Washington Times stories: Politics · Bias: Center Right

Summary

The Food and Drug Administration plans to drop its longtime standard of requiring two rigorous studies to win approval for new drugs, the latest change from Trump administration officials vowing to speed up the availability of certain medical products.

Related Coverage

More Headlines From February 18, 2026

FDA will drop two-study requirement for new drug approvals, aiming to speed access
The Washington Times stories: Politics

FDA will drop two-study requirement for new drug approvals, aiming to speed access

Center Right

The Food and Drug Administration plans to drop its longtime standard of requiring two rigorous studies to win approval for new drugs, the latest change from Trump administration officials vowing to speed up the availability of certain medical products.